Navigation Links
Astellas Oncology Announces New Data in Acute Myeloid Leukemia to be Presented at the 2016 ASH Annual Meeting
Date:11/17/2016

NORTHBROOK, Ill., Nov. 17, 2016 /PRNewswire/ -- Astellas today announced two gilteritinib abstracts, including an oral presentation in patients with relapsed or refractory (R/R) acute myeloid leukemia (AML), that will be presented at the 58th American Society of Hematology (ASH) Annual Meeting and Exposition, Dec. 3-6 in San Diego.

The following abstract will be presented during an oral presentation session:

Continue Reading
Astellas is a pharmaceutical company dedicated to improving the health of people around the world.
Astellas is a pharmaceutical company dedicated to improving the health of people around the world.

Title: Final Results of the Chrysalis Trial: A First-in-Human Phase 1/2 Dose-Escalation, Dose-Expansion Study of Gilteritinib (ASP2215) in Patients with Relapsed/Refractory Acute Myeloid Leukemia (R/R AML). (Abstract 1069)

Presenter: Alexander E. Perl, M.D., University of Pennsylvania-Abramson Comprehensive Cancer Center, Philadelphia, Pa.

  • Session Date/Time: Monday, Dec. 5 at 4:30 p.m. PST
  • Location: San Diego Ballroom AB (Marriott Marquis San Diego Marina)

In addition to the oral presentation, Astellas will present the following abstract in a poster session:

Title: Gilteritinib (ASP2215), a Novel FLT3/AXL Inhibitor: Preclinical Evaluation in Combination with Azacitidine in Acute Myeloid Leukemia (Yoko Ueno, PhD) (Abstract 2830)

  • Session Date/Time: Sunday, Dec. 4 from 6:00 p.m. to 8:00 p.m. PST
  • Location: Hall GH (San Diego Convention Center)

About Astellas

Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. For more information on Astellas, please visit our website at www.astellas.us. You can also follow us on Twitter at @AstellasUS, Facebook at www.facebook.com/AstellasUS or LinkedIn at www.linkedin.com/company/astellas-pharma.

Logo - http://photos.prnewswire.com/prnh/20140416/84970

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/astellas-oncology-announces-new-data-in-acute-myeloid-leukemia-to-be-presented-at-the-2016-ash-annual-meeting-300365503.html


'/>"/>
SOURCE Astellas
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen
2. Amgen And Astellas Announce Japan Alliance
3. Molly Fletcher to Speak at Astellas Presents Executive Womens Day at the FedEx St. Jude Classic
4. Astellas Signs Distribution Agreement With Tecnofarma For Enzalutamide In Latin America
5. Molly Fletcher to Speak at Astellas Presents Executive Womens Day at the AT&T National
6. Dr. Helen Fisher to Speak at Astellas Presents Executive Womens Day at the Constellation SENIOR PLAYERS Championship
7. Astellas Appoints New Senior Vice President of Global Oncology Development
8. Astellas Confirms Interim Analysis in PREVAIL Study of XTANDI will Occur within Calendar Year 2013
9. Astellas to Host Executive Womens Day at 2013 TOUR Championship by Coca-Cola
10. Astellas Employees to Change Tomorrow through Annual Day of Service
11. Astellas US Appoints Senior Vice President, Chief Communications Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/7/2017)... GAITHERSBURG, Md. , Aug. 7, 2017 /PRNewswire/ ... for healthcare member acquisition, retention, and engagement, announced ... Director of Strategy and Product Development, effective as ... strategic consulting and technology implementation strategy for our ... years of experience in consulting and business analytics ...
(Date:8/4/2017)... , Aug. 4, 2017 The search for ... after a physician/patient consult has long been the goal ... a notable focus of the largest meeting of lab ... to healthcare market research firm Kalorama Information.  The firm ... (POCT) offerings or related supplies and software were at ...
(Date:8/2/2017)... AURORA, Ore. , Aug. 2, 2017  Life Flight ... Call Agreement. The agreement improves patient care and operational efficiency ... Springfield , Cottage Grove ... ICU level medical transportation. PeaceHealth and Life Flight Network work ... care available during transport, or when a time sensitive emergency ...
Breaking Medicine Technology:
(Date:8/19/2017)... ... August 19, 2017 , ... Praeclarus Press ... mothers. These illustrations show the diversity of the breastfeeding mothers, using bright ... range of sizes. These illustrations are also available on tote bags, notepads, smartphone ...
(Date:8/18/2017)... ... 19, 2017 , ... Mr. Noppadon Pakprot, Deputy Governor for ... Health and Wellness Tourism Showcase 2017 yesterday, which unveiled the latest “Functional & ... Products and Business at TAT said, “Thailand has long been recognized as a ...
(Date:8/18/2017)... ... August 18, 2017 , ... August 18, ... & Hearing,” advocating for active, healthy lifestyles and highlighting the importance of proactive ... with hearing impairments and shares the latest innovations in hearing aid technology. ...
(Date:8/18/2017)... WV (PRWEB) , ... August 18, 2017 , ... ... financial consulting services and asset protection assistance to communities in North-Central West Virginia, ... provide critical services to at-risk boys in the area. , The Chestnut Mountain ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... The Golseth ... in the Dallas/Fort Worth area, is spearheading a regional charity campaign organized to provide ... , In early June of this year, Christina and her children returned from out ...
Breaking Medicine News(10 mins):